The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited regarding their quarterly financial results filing for the quarter ended 31 March 2026. The query is under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs financial results disclosure requirements. The specific details of the clarification sought are not disclosed in the filing. The company's response to the exchange query is currently awaited.
This appears to be a routine compliance query from the exchange. The stock may see minor caution until the clarification is provided, but such queries are common and often involve minor documentation or disclosure details rather than substantive concerns.